COVID-19 vaccinations summary

Second Boosters Administered 1,127,006
Total Doses Administered 14,011,903
First Boosters Administered 2,788,265
Percentage of 12+ who have completed primary course 83.1%
Percentage of eligible 50+ who have received second booster 57.2%
Percentage of eligible 18+ who have received first booster 71.1%

 

Metrics on this page can use one of two views of the data - An operational view or a person view.

All data comes from the Aotearoa Immunisation Register (AIR). The operational view shows all doses administered in New Zealand. The person view shows the vaccination status of people regardless of how that was recorded or whether it was in New Zealand. Those who have been vaccinated overseas will only appear in the person view; they will not appear in the operational view. The person view includes all people that are currently alive and in AIR. On 12 June 2024, the estimated population was changed to be sourced from AIR instead of the most recent Health Service User (HSU).

Total vaccinations

  Vaccinations last week Cumulative total
Primary Course Doses (12+) 52 8,027,316
Booster 1 50 2,788,265
Booster 2 205 1,127,006
Booster 3+ 3,700 1,636,584
Paediatric First Dose 6 273,074
Paediatric Second Dose 1 159,084
Infant First Dose 1 241
Infant Second Dose 0 153
Infant Third Dose 1 180
Total doses 4,016 14,011,903

 

This table is an operational view.

Definitions

  • Cumulative total: All vaccinations that have been administered and entered into the Aotearoa Immunisation Register and including Sunday 26 October 2025.
  • Vaccinations last week:  Over the 7 days up to and including Sunday 26 October 2025.

Booster breakdowns

Booster counts by ethnicity

Ethnicity Booster 1 (16-17) Booster 1 (18+) Booster 2 (50+)
Māori 185 260,463 70,106
Pacific Peoples 78 155,738 30,196
Asian 217 470,838 69,517
Other 1,146 1,805,745 708,449
Total 1,626 2,692,784 878,268

 

This table is a person view.

Booster 2 uptake by age group

Age Group Eligible Received Uptake
30 to 34 201,864 41,883 20.7%
35 to 49 645,376 141,296 21.9%
50 to 64 723,671 291,626 40.3%
65+ 810,423 586,642 72.4%

 

This table is a person view.

Vaccine uptake percentage by age band

A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand.

Vaccine uptake percentage by District of residence 12+

A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered.

*Note, this figure does not include 0-11 year olds

*Note, this figure does not include 0-11 year olds

Vaccinations by week

A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week.

* Note, Third Booster + is defined as any booster dose received after a person’s second booster.

* Note, Third Booster + is defined as any booster dose received after a person’s second booster.

This chart shows the count of vaccinations administered in a given week from the Aotearoa Immunisation Register.

Note some records are entered in the register at a later date than the immunisation was received. This means that the figures for a given date may move for some time after that date.

Adverse events following immunisations (AEFI)

Like all medicines, the COVID-19 vaccine may cause side effects in some people. These are common, are usually mild, don’t last long and won’t stop people from having the second dose or going about daily life. Serious allergic reactions do occur but are extremely rare.

Suspected AEFI to COVID-19 vaccines are reported to the Centre for Adverse Reactions Monitoring (CARM). While Medsafe no longer publishes their COVID-19 vaccine safety reports, they continue to monitor reports of adverse reactions submitted to CARM.

More information